- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Ulthera, Inc
Total 35888 results
-
Cothera Bioscience, IncRecruitingLymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphatic Diseases | Burkitt Lymphoma | High-grade B-cell Lymphoma | C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma | C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma | Lymphoma, High-Grade | C-Myc Gene RearrangementKorea, Republic of, China
-
ImThera Medical, Inc.CompletedSleep Apnea Syndromes | Sleep Apnea, Obstructive | Respiration Disorders | Signs and Symptoms, Respiratory | Syndrome, Obstructive Sleep ApneaUnited States, France, Belgium, Germany, Italy
-
ImThera Medical, Inc.LivaNovaCompletedObstructive Sleep ApneaUnited States, Israel, France, Belgium, Germany, Portugal
-
ImThera Medical, Inc.CompletedSleep Apnea Syndromes | Sleep Apnea, Obstructive | Respiration Disorders | Signs and Symptoms, Respiratory | Syndrome, Obstructive Sleep ApneaBelgium
-
AstraZenecaMedpace, Inc.; Omthera Pharmaceuticals, IncCompletedCardiovascular Disease | HypertriglyceridemiaUnited States
-
OxTheraCompletedPrimary HyperoxaluriaUnited States
-
Ulthera, IncUniversity of Texas Southwestern Medical CenterCompletedMild to Moderate Skin Laxity on Cheek | Mild to Moderate Skin Laxity on Upper Neck | Mild to Moderate Subcutaneous Fat on Cheek | Mild to Moderate Subcutaneous Fat on Upper Neck
-
OxTheraTerminatedHyperoxaluria, PrimaryUnited Kingdom, Spain, Belgium, United States, Germany, Tunisia
-
OxTheraCompletedPrimary HyperoxaluriaFrance, United Kingdom, Spain, Belgium, United States, Germany, Tunisia
-
Kythera BiopharmaceuticalsCompletedHealthy | Submental FatUnited States, Canada, Australia, United Kingdom
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
Kythera BiopharmaceuticalsCompletedSubmental FullnessUnited States, Canada
-
Anthera PharmaceuticalsCompletedCystic Fibrosis | Exocrine Pancreatic InsufficiencyUnited States, Hungary, Israel, Poland, Spain, Czechia
-
Anthera PharmaceuticalsUnknownCystic Fibrosis | Exocrine Pancreatic InsufficiencyUnited States, Hungary, Israel, Lithuania, Poland, Spain, United Kingdom
-
Anthera PharmaceuticalsTerminatedSystemic Lupus ErythematosusGeorgia
-
Anthera PharmaceuticalsCompletedSystemic Lupus ErythematosusGeorgia, Belarus, Brazil, Colombia, Guatemala, Hong Kong, India, Korea, Republic of, Malaysia, Mexico, Philippines, Russian Federation, Singapore, Sri Lanka, Taiwan, Thailand
-
Kythera BiopharmaceuticalsCompleted
-
Anthera PharmaceuticalsWithdrawnIdiopathic Thrombocytopenic Purpura | Immune Thrombocytopenic Purpura
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessAustralia, Canada, United Kingdom
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States
-
Anthera PharmaceuticalsCompletedCystic Fibrosis | Exocrine Pancreatic InsufficiencyUnited States
-
Kythera BiopharmaceuticalsCompleted
-
Anthera PharmaceuticalsCompletedSickle Cell Disease | Acute Chest Syndrome | Vaso-occlusive CrisisUnited States
-
Kythera BiopharmaceuticalsCompleted
-
Kythera BiopharmaceuticalsCompleted
-
Anthera PharmaceuticalsCompletedCoronary Artery Disease (CAD)United States, Ukraine
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
Anthera PharmaceuticalsCompletedCystic Fibrosis | Exocrine Pancreatic InsufficiencyUnited States, Hungary, Israel, Poland, Spain, Canada, Czechia
-
Anthera PharmaceuticalsCompletedCystic Fibrosis | Exocrine Pancreatic InsufficiencyUnited States
-
Kythera BiopharmaceuticalsCompleted
-
Anthera PharmaceuticalsWithdrawn
-
Anthera PharmaceuticalsWithdrawnMicroscopic Polyangiitis | Granulomatosis With Polyangiitis
-
Anthera PharmaceuticalsWithdrawn
-
Kythera BiopharmaceuticalsCompletedPhase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat (ATX-101)Moderate or Severe Submental FullnessUnited Kingdom, Canada, Australia
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States, Canada
-
Anthera PharmaceuticalsTerminated
-
Anthera PharmaceuticalsCompletedCystic Fibrosis | Exocrine Pancreatic InsufficiencyUnited States
-
Anthera PharmaceuticalsCompletedSystemic Lupus ErythematosusUnited States, Argentina, Brazil, Chile, Colombia, Hong Kong, India, Mexico, Peru, Philippines, Taiwan
-
Kythera BiopharmaceuticalsCompleted
-
Kythera BiopharmaceuticalsCompleted
-
Anthera PharmaceuticalsCompletedCoronary Artery DiseaseUnited States
-
Kythera BiopharmaceuticalsCompletedHealthy | Submental FatUnited States, Canada
-
Anthera PharmaceuticalsCompletedIgA NephropathyCzechia, Germany, Hong Kong, Korea, Republic of, Malaysia, Philippines, Singapore, Taiwan, Thailand, United Kingdom
-
Kythera BiopharmaceuticalsCompleted
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States, Canada
-
Anthera PharmaceuticalsCompletedAcute Coronary SyndromeRussian Federation, Georgia, Ukraine
-
Anthera PharmaceuticalsTerminatedSickle Cell Disease | Vaso-occlusive CrisisUnited States